Albinterferon alfa‐2b dosed every two or four weeks in interferon‐naïve patients with genotype 1 chronic hepatitis C†‡

200880 citationsJournal Articlebronze Open Access

Authors

Alb-IFN administered q2wk or q4wk may offer comparable efficacy, with an improved dosing schedule, compared with PEG-IFNalpha-2a.

Good health and well-being

Published in: Hepatology

Volume 48, Issue 2, pp. 407-417

Field-Weighted Citation Impact: 8.47